quantitative neuroimaging to clinical settings
for better patient care

CorticoMetrics’ FDA 510(k)-cleared product, called THINQ™, is not currently offered for sale.  It is indicated for clinical use by neurologists, radiologists and neuroradiologists in the post-acquisition quantitative analysis of MRI brain scans. 

product and technology

THINQ targets problems faced by radiologists and neurologists


CorticoMetrics’ FDA 510(k)-cleared product, called THINQ™, is not currently offered for sale.

Clinical decision-making in neuroradiology is often based on qualitative assessment…
two parts of
About us

AI-based software for advanced imaging

CorticoMetrics was formed in 2012 to commercialize neuroimaging analysis software developed at the Massachusetts General Hospital (MGH), known to researchers worldwide as FreeSurfer. It was co-founded by Dr. Bruce Fischl, the Director of the Laboratory for Computational Neuroimaging (home of FreeSurfer) and Mr. Nick Schmansky, formerly the lab’s Lead Software Engineer.

medical scientist working
Our Team

Experienced Leadership in Driving Innovation

headshot of a

Nick Schmansky

Co-Founder & CEO
headshot of a

Bruce Fischl, PhD

Co-Founder & Scientific Advisor
headshot of a

Lee Tirrell

Software Engineer & Data Scientist
headshot of a

Karen Roberts, PhD

Business Advisor

Our technology aims to improve the overall quality of patient outcome

THINQ, the product created by CorticoMetrics through prior SBIR/STTR grants, targets this problem faced by radiologists and neurologists by quantifying the size of critical brain structures and presenting the measures alongside normative reference data.
Our latest Press Releases
doctor shows geometric

CorticoMetrics Announces FDA 510(k) Clearance of THINQ™ for MRI Brain Volumetric Reporting

portrait of a

NIH-NIA Fast-Track STTR Award

medical scientist working

THINQ distribution partnership announcement coming soon!